QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-maintains-buy-on-repare-therapeutics-lowers-price-target-to-3

HC Wainwright & Co. analyst Robert Burns maintains Repare Therapeutics (NASDAQ:RPTX) with a Buy and lowers the price tar...

 hc-wainwright--co-maintains-buy-on-repare-therapeutics-lowers-price-target-to-3

HC Wainwright & Co. analyst Robert Burns maintains Repare Therapeutics (NASDAQ:RPTX) with a Buy and lowers the price tar...

 repare-therapeutics-to-share-initial-topline-safety-tolerability-and-early-efficacy-data-from-phase-1-lions-trial-in-poster-presentation-at-aacr-nci-eortc-international-conference-2025

Repare Therapeutics Inc. ("Repare" or the "Company") (NASDAQ:RPTX), a clinical-stage precision oncology company...

 repare-therapeutics-q1-eps-071-misses-066-estimate

Repare Therapeutics (NASDAQ:RPTX) reported quarterly losses of $(0.71) per share which missed the analyst consensus estimate of...

 repare-therapeutics-out-licenses-its-discovery-platforms-to-dcx-biotherapeutics-will-receive-4m-upfront-and-999-common-equity-position-in-dcx-and-is-eligible-for-milestone-payments-and-royalties

Under the terms of the out-licensing agreement, Repare will receive upfront and near-term payments totaling $4 million, as well...

 cathie-woods-ark-invest-offloads-uipath-prime-medicine-and-repare-therapeutics

On April 11th, 2025, Cathie Wood's Ark Invest sold shares in UiPath, Prime Medicine, and Repare Therapeutics, with notable ...

 cathie-wood-doubles-down-mops-up-another-139-million-worth-of-robinhood-stock-amid-trump-tariff-dip

On Thursday, April 3, 2025, Cathie Wood-led Ark Invest purchased Robinhood stock worth $1.39 million amid a broader market slump.

 repare-therapeutics-names-steve-forte-as-president-and-ceo-effective-april-11-2025-lloyd-m-segal-resigns

He will serve in this new role in addition to his current role as the Company's Chief Financial Officer.Additionally, Sandr...

 cathie-woods-ark-invest-loads-up-on-robinhood-nvidia-backed-coreweave-offloads-spotify-roku

Cathie Wood-led Ark Invest made substantial trades, buying Robinhood and CoreWeave shares and selling Roblox, Genius Sports, Ro...

 cathie-woods-ark-invest-scoops-up-iridium-beam-pacific-biosciences-while-offloading-illumina-and-amgen

Cathie Wood-led Ark Invest made notable trades, buying IRDM, BEAM, PACB, ABSI and selling ILMN, RPTX, AMGN, VEEV.

 cathie-woods-ark-invest-continues-to-offload-uipath-roblox-loads-up-on-gitlab-ibotta

Ark Invest's Cathie Wood-led funds made significant trades involving GitLab, Intellia, Prime Medicine, UiPath, Ibotta, Robl...

 hc-wainwright--co-maintains-buy-on-repare-therapeutics-lowers-price-target-to-5

HC Wainwright & Co. analyst Robert Burns maintains Repare Therapeutics (NASDAQ:RPTX) with a Buy and lowers the price tar...

 repare-announced-a-re-alignment-of-resources-and-a-re-prioritization-of-its-clinical-portfolio-to-focus-on-rp-1664-and-rp-3467-in-connection-with-the-re-alignment-the-company-is-reducing-its-workforce-by-approximately-75

Exploring partnerships across portfolio, including for Lunre+Camo

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION